Moran Kyle
Chief Financial Officer at WVE
- Sold, on record
- $4.7M
- Dollars the filings state
- Form 4 sales
- 9
- Latest Feb 9, 2026
- Form 144 notices
- 3
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- WVEWave Life Sciences Ltd.Chief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice WVENoticeAug 23, 2023 2023
Filed to sell 37,062 shares ($176k)
Moran Kyle, Officer
10b5-1 plan4x usual sizeFiling
- 2 Form 4 sale WVEUnusualAug 23, 2023 same day
Sold 37,062 shares at $4.75 ($176k)
Moran Kyle, Chief Financial Officer
10b5-1 planSold 44.6% of holdings ($395k position)46,120 shares left4x usual sizeFollows a Form 144Filing
- 3 Form 144 notice WVENoticeApr 3, 2024 +224 days
Filed to sell 15,630 shares ($96k)
Moran Kyle, Officer
10b5-1 plan1.6x usual sizeFiling
- 4 Form 4 sale WVERoutineApr 3, 2024 same day
Sold 15,630 shares at $6.17 ($96k)
Moran Kyle, Chief Financial Officer
10b5-1 planSold 31.5% of holdings ($306k position)33,921 shares left1.6x usual sizeFollows a Form 144Filing
- 5 Form 144 notice WVENoticeSep 25, 2024 +175 days
Filed to sell 17,146 shares ($154k)
Moran Kyle, Officer
10b5-1 plan1.1x usual sizeFiling
- 6 Form 4 sale WVERoutineSep 25, 2024 same day
Sold 17,146 shares at $9.00 ($154k)
Moran Kyle, Chief Financial Officer
10b5-1 planSold 46.4% of holdings ($332k position)19,777 shares left1.1x usual sizeFollows a Form 144Filing
- 7 Form 4 sale WVERoutineDec 9, 2025 +440 days
Sold 260,036 shares at $15.78 ($4.1M)
Moran Kyle, Chief Financial Officer
10b5-1 planSold 74.2% of holdings ($5.5M position)90,365 shares leftFiling
- 8 Form 4 sale WVENo planFeb 9, 2026 +62 days
Sold 3,588 shares at $13.45 ($48k)
Moran Kyle, Chief Financial Officer
No 10b5-1 planSold 2.6% of holdings ($1.9M position)134,385 shares left0.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (12)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 9, 2026 | Feb 11, 2026 | WVE | Chief Financial Officer | Form 4 sale | 3,588 | $48k | 2.6% | No plan | SEC |
| Dec 9, 2025 | Dec 10, 2025 | WVE | Chief Financial Officer | Form 4 sale | 260,036 | $4.1M | 74.2% | Routine | SEC |
| Sep 25, 2024 | Sep 27, 2024 | WVE | Chief Financial Officer | Form 4 sale | 17,146 | $154k | 46.4% | Routine | SEC |
| Sep 25, 2024 | Sep 25, 2024 | WVE | Officer | Form 144 notice | 17,146 | $154k | Notice | SEC | |
| Apr 3, 2024 | Apr 5, 2024 | WVE | Chief Financial Officer | Form 4 sale | 15,630 | $96k | 31.5% | Routine | SEC |
| Apr 3, 2024 | Apr 3, 2024 | WVE | Officer | Form 144 notice | 15,630 | $96k | Notice | SEC | |
| Aug 23, 2023 | Aug 23, 2023 | WVE | Chief Financial Officer | Form 4 sale | 37,062 | $176k | 44.6% | Unusual | SEC |
| Aug 23, 2023 | Aug 23, 2023 | WVE | Officer | Form 144 notice | 37,062 | $176k | Notice | SEC | |
| Feb 16, 2023 | Feb 17, 2023 | WVE | Chief Financial Officer | Form 4 sale | 9,729 | $39k | 10.9% | Plan not stated | SEC |
| May 5, 2022 | May 6, 2022 | WVE | Chief Financial Officer | Form 4 sale | 5,021 | $9k | 5.6% | Plan not stated | SEC |
| Feb 16, 2022 | Feb 18, 2022 | WVE | Chief Financial Officer | Form 4 sale | 9,204 | $21k | 11.0% | Plan not stated | SEC |
| Feb 16, 2021 | Feb 18, 2021 | WVE | Chief Financial Officer | Form 4 sale | 1,722 | $18k | 2.4% | Plan not stated | SEC |